These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 19109336

  • 21. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
    Le Floch R, Arnould JF, Vinsonneau C, Hovsepian L, Stephanazzi J, Bret P, Birraux G, Lovering AM.
    Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
    [Abstract] [Full Text] [Related]

  • 22. Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections.
    Traunmüller F, Schintler MV, Spendel S, Popovic M, Mauric O, Scharnagl E, Joukhadar C.
    Int J Antimicrob Agents; 2010 Jul; 36(1):84-6. PubMed ID: 20456925
    [Abstract] [Full Text] [Related]

  • 23. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
    Plock N, Buerger C, Joukhadar C, Kljucar S, Kloft C.
    Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
    Santos RP, Prestidge CB, Brown ME, Urbancyzk B, Murphey DK, Salvatore CM, Jafri HS, McCracken GH, Ahmad N, Sanchez PJ, Siegel JD.
    Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
    [Abstract] [Full Text] [Related]

  • 25. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
    Gordi T, Tan LH, Hong C, Hopkins NJ, Francom SF, Slatter JG, Antal EJ.
    J Clin Pharmacol; 2003 Oct; 43(10):1161-7. PubMed ID: 14517199
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.
    Tsuji Y, Hiraki Y, Matsumoto K, Mizoguchi A, Sadoh S, Kobayashi T, Sakamoto S, Morita K, Yukawa E, Kamimura H, Karube Y.
    Scand J Infect Dis; 2012 Aug; 44(8):626-9. PubMed ID: 22263918
    [Abstract] [Full Text] [Related]

  • 27. Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients.
    Pea F, Viale P, Lugano M, Baccarani U, Pavan F, Tavio M, Adani GL, Della Rocca G, Furlanut M.
    J Antimicrob Chemother; 2009 Jan; 63(1):167-9. PubMed ID: 18952619
    [Abstract] [Full Text] [Related]

  • 28. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
    Hoyo I, Martínez-Pastor J, Garcia-Ramiro S, Climent C, Brunet M, Cuesta M, Mensa J, Soriano A.
    Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321
    [Abstract] [Full Text] [Related]

  • 29. Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection.
    Stein GE, Throckmorton JK, Scharmen AE, Weiss WJ, Prokai L, Smith CL, Havlichek DH.
    J Antimicrob Chemother; 2013 Dec; 68(12):2852-8. PubMed ID: 23873647
    [Abstract] [Full Text] [Related]

  • 30. Human vitreous distribution of linezolid after a single oral dose.
    Ciulla TA, Comer GM, Peloquin C, Wheeler J.
    Retina; 2005 Dec; 25(5):619-24. PubMed ID: 16077360
    [Abstract] [Full Text] [Related]

  • 31. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
    Meyer B, Kornek GV, Nikfardjam M, Karth GD, Heinz G, Locker GJ, Jaeger W, Thalhammer F.
    J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
    [Abstract] [Full Text] [Related]

  • 32. Penetration of linezolid into the anterior chamber (aqueous humor) of the human eye after intravenous administration.
    Vázquez EG, Mensa J, López Y, Couchard PD, Soy D, Fontenla JR, Sarasa M, Carné X, Montull E.
    Antimicrob Agents Chemother; 2004 Feb; 48(2):670-2. PubMed ID: 14742235
    [Abstract] [Full Text] [Related]

  • 33. Effect of severity of sepsis on tissue concentrations of linezolid.
    Thallinger C, Buerger C, Plock N, Kljucar S, Wuenscher S, Sauermann R, Kloft C, Joukhadar C.
    J Antimicrob Chemother; 2008 Jan; 61(1):173-6. PubMed ID: 17999976
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and protein binding of linezolid in cerebrospinal fluid and serum in a case of post-neurosurgical bacterial meningitis.
    Tsuji Y, Hiraki Y, Matsumoto K, Mizoguchi A, Sadoh S, Kobayashi T, Takemura Y, Sakamoto S, Morita K, Kamimura H, Karube Y.
    Scand J Infect Dis; 2011 Dec; 43(11-12):982-5. PubMed ID: 21851332
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.
    Stolle LB, Plock N, Joukhadar C, Arpi M, Emmertsen KJ, Buerger C, Riegels-Nielsen P, Kloft C.
    Scand J Infect Dis; 2008 Dec; 40(1):24-9. PubMed ID: 18097982
    [Abstract] [Full Text] [Related]

  • 37. Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.
    Eslam RB, Burian A, Vila G, Sauermann R, Hammer A, Frenzel D, Minichmayr IK, Kloft C, Matzneller P, Oesterreicher Z, Zeitlinger M.
    J Clin Pharmacol; 2014 Sep; 54(9):1058-62. PubMed ID: 24677034
    [Abstract] [Full Text] [Related]

  • 38. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
    Luque S, Grau S, Alvarez-Lerma F, Ferrández O, Campillo N, Horcajada JP, Basas M, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
    [Abstract] [Full Text] [Related]

  • 39. Disposition of linezolid in the isolated rat lung after systemic and pulmonary drug delivery.
    de Jesús Valle MJ, Uranga NS, López FG, Hurlé AD, Navarro AS.
    J Antimicrob Chemother; 2007 Nov; 60(5):1074-9. PubMed ID: 17827144
    [Abstract] [Full Text] [Related]

  • 40. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
    Matsumoto K, Takeshita A, Ikawa K, Shigemi A, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K.
    Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.